Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Artificial Muscles: Dielectric Elastomers Responsive to Low Voltages.

Sheima Y, Caspari P, Opris DM.

Macromol Rapid Commun. 2019 Aug;40(16):e1900205. doi: 10.1002/marc.201900205. Epub 2019 Jun 17.

PMID:
31206943
2.

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.

Hartman L, Rasch LA, Klausch T, Bijlsma HWJ, Christensen R, Smulders YM, Ralston SH, Buttgereit F, Cutolo M, Da Silva JAP, Opris D, Rovenský J, Szamosi S, Middelink LM, Lems WF, Boers M.

Trials. 2018 Jan 25;19(1):67. doi: 10.1186/s13063-017-2396-3.

3.

Polar Elastomers as Novel Materials for Electromechanical Actuator Applications.

Opris DM.

Adv Mater. 2018 Feb;30(5). doi: 10.1002/adma.201703678. Epub 2017 Dec 4. Review.

PMID:
29205519
4.

Assessment of skin involvement in systemic sclerosis.

Kumánovics G, Péntek M, Bae S, Opris D, Khanna D, Furst DE, Czirják L.

Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v53-v66. doi: 10.1093/rheumatology/kex202. Review.

5.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
6.

The relationship between disease activity, quality of life, and personality types in rheumatoid arthritis and ankylosing spondylitis patients.

Donisan T, Bojincă VC, Dobrin MA, Bălănescu DV, Predețeanu D, Bojincă M, Berghea F, Opriș D, Groșeanu L, Borangiu A, Constantinescu CL, Ionescu R, Bălănescu AR.

Clin Rheumatol. 2017 Jul;36(7):1511-1519. doi: 10.1007/s10067-017-3654-1. Epub 2017 Apr 27.

PMID:
28451872
7.

An All-Organic Elastomeric Electret Composite.

Ko YS, Nüesch FA, Damjanovic D, Opris DM.

Adv Mater. 2017 Jan;29(1). doi: 10.1002/adma.201603813. Epub 2016 Oct 26.

PMID:
27783431
8.

Low vitamin D status in systemic sclerosis and the impact on disease phenotype.

Groseanu L, Bojinca V, Gudu T, Saulescu I, Predeteanu D, Balanescu A, Berghea F, Opris D, Borangiu A, Constantinescu C, Negru M, Ionescu R.

Eur J Rheumatol. 2016 Jun;3(2):50-55. Epub 2016 Feb 1.

9.

Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central-eastern Europe.

Szántó S, Poór G, Opris D, Iaremenko O, Procházková L, Kuuse R, Nagy O, Chernyshov V, Géher P.

J Comp Eff Res. 2016 Aug;5(5):475-85. doi: 10.2217/cer-2016-0020. Epub 2016 Jul 15.

PMID:
27417564
10.

Is exposure to Agent Orange a risk factor for hepatocellular cancer?-A single-center retrospective study in the U.S. veteran population.

Krishnamurthy P, Hazratjee N, Opris D, Agrawal S, Markert R.

J Gastrointest Oncol. 2016 Jun;7(3):426-32. doi: 10.21037/jgo.2016.01.09.

11.

Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?

Dima A, Opris D, Jurcut C, Baicus C.

Lupus. 2016 Oct;25(11):1173-9. doi: 10.1177/0961203316651742. Epub 2016 Jun 2. Review.

PMID:
27256317
12.

Clinical Phenotype of Endothelial Dysfunction in Romanian Scleroderma Patients.

Groseanu L, Berghea F, Balanescu A, Predeteanu D, Bojinca V, Saulescu I, Constantinescu C, Opris D, Abobului M, Borangiu A, Negru MM, Vlad V, Ionescu R.

Maedica (Buchar). 2016 Mar;11(1):26-31.

13.

Dual X-ray Absorptiometry Whole Body Composition of Adipose Tissue in Rheumatoid Arthritis.

Popescu C, Bojincă V, Opriş D, Ionescui R.

Rom J Intern Med. 2015 Jul-Sep;53(3):237-47.

PMID:
26710499
14.

Socio-economical factors that influence the perception of quality of life in patients with osteoporosis.

Abobului M, Berghea F, Vlad V, Balanescu A, Opris D, Bojinca V, Predeteanu D, Ionescu R.

J Med Life. 2015;8 Spec Issue:109-14. Erratum in: J Med Life. 2015;8 Spec Issue:124.

15.

Evaluation of adherence to anti-osteoporosis treatment from the socio-economic context.

Abobului M, Berghea F, Vlad V, Balanescu A, Opris D, Bojinca V, Kosevoi Tichie A, Predeteanu D, Ionescu R.

J Med Life. 2015;8 Spec Issue:119-23. Erratum in: J Med Life. 2015;8 Spec Issue:124.

16.

Clinical Phenotype of Endothelial Dysfunction in a Lot of Romanian Scleroderma Patients.

Groseanu L, Berghea F, Balanescu A, Predeteanu D, Bojinca V, Saulescu I, Constantinescu C, Opris D, Abobului M, Borangiu A, Negru MM, Vlad V, Ionescu R.

Maedica (Buchar). 2015 Sep;10(4):336-341.

17.
18.

Treatment of Anterior Instability of the Shoulder.

Vlase M, Ene R, Opris D, Cirstoiu C.

Maedica (Buchar). 2015 Jun;10(2):112-116.

19.

Monitoring drug and antidrug levels: a rational approach in rheumatoid arthritis patients treated with biologic agents who experience inadequate response while being on a stable biologic treatment.

Mazilu D, Opriş D, Gainaru C, Iliuta M, Apetrei N, Luca G, Borangiu A, Gudu T, Peltea A, Groseanu L, Constantinescu C, Saulescu I, Bojinca V, Balanescu A, Predeteanu D, Ionescu R.

Biomed Res Int. 2014;2014:702701. doi: 10.1155/2014/702701. Epub 2014 May 20.

20.

Effects of hypnotic analgesia and virtual reality on the reduction of experimental pain among high and low hypnotizables.

Enea V, Dafinoiu I, Opriş D, David D.

Int J Clin Exp Hypn. 2014;62(3):360-77. doi: 10.1080/00207144.2014.901087.

PMID:
24837064
21.

Whole body bone tissue and cardiovascular risk in rheumatoid arthritis.

Popescu C, Bojincă V, Opriş D, Ionescu R.

J Osteoporos. 2014;2014:465987. doi: 10.1155/2014/465987. Epub 2014 Apr 8.

22.

Statins do not influence long-term rituximab clinical efficiency in rheumatoid arthritis patients.

Mazilu D, Gudu T, Ionescu R, Opris D.

Biomed Res Int. 2014;2014:689426. doi: 10.1155/2014/689426. Epub 2014 Jan 8.

23.

Serotonin and the bone assessment.

Carsote M, Radoi V, Geleriu A, Mihai A, Ferechide D, Opris D, Paun D, Poiana C.

J Med Life. 2014;7 Spec No. 2:49-53.

24.

The serotonin and the bone assessment.

Carsote M, Radoi V, Geleriu A, Mihai A, Ferechide D, Opris D, Paun D, Poiana C.

J Med Life. 2013 Jun 15;6(2):151-5. Epub 2013 Jun 25. Erratum in: J Med Life. 2015;8 Spec Issue:124.

25.

Virtual reality exposure therapy in anxiety disorders: a quantitative meta-analysis.

Opriş D, Pintea S, García-Palacios A, Botella C, Szamosközi Ş, David D.

Depress Anxiety. 2012 Feb;29(2):85-93. doi: 10.1002/da.20910. Epub 2011 Nov 7.

PMID:
22065564
26.

Deterministic and stochastic model for the role of the immune response time delay in periodic therapy of the tumors.

Chiş O, Neamtu M, Opriş D.

Curr Comput Aided Drug Des. 2011 Dec;7(4):338-50.

PMID:
22050677
27.

"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity.

Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M.

Semin Arthritis Rheum. 2012 Feb;41(4):589-98. doi: 10.1016/j.semarthrit.2011.07.010. Epub 2011 Sep 29.

PMID:
21959290
28.

Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients.

Besliu A, Banica L, Predeteanu D, Vlad V, Ionescu R, Pistol G, Opris D, Berghea F, Stefanescu M, Matache C.

Autoimmunity. 2011 Aug;44(5):427-36. doi: 10.3109/08916934.2010.541171. Epub 2011 Jan 19.

PMID:
21244334
29.

Detection of homocysteine and C-reactive protein in the saliva of healthy adults: comparison with blood levels.

Dillon MC, Opris DC, Kopanczyk R, Lickliter J, Cornwell HN, Bridges EG, Nazar AM, Bridges KG.

Biomark Insights. 2010 Jul 20;5:57-61.

30.

Anti-cyclic citrullinated peptide antibodies--activity markers in rheumatoid arthritis.

Predeteanu D, Varzaru L, Balanescu A, Bojinca V, Opris D, Vlad V, Berghea F, Abobului M, Constantinescu C, Ionescu R.

J Med Life. 2009 Jan-Mar;2(1):36-41.

31.

A set of homologous hetarylenediyne macrocycles by oxidative acetylene-acetylene coupling.

Opris DM, Ossenbach A, Lentz D, Schlüter AD.

Org Lett. 2008 Jun 5;10(11):2091-3. doi: 10.1021/ol800316b. Epub 2008 May 8.

PMID:
18461946
32.
33.

Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.

Opriş D, Iosif CI, Predeţeanu D.

Rom J Intern Med. 2004;42(4):715-23.

PMID:
16366143
34.

Peptide property modeling by Cluj indices.

Opris D, Diudea MV.

SAR QSAR Environ Res. 2001;12(1-2):159-79.

PMID:
11697054

Supplemental Content

Support Center